Moderna and Catalent in an agreement to pack the Covid vaccine

Modern (MRNA) – Get report and catalent (CTLT) – Get report unveiled a joint effort to free the Moderna coronavirus vaccine candidate this quarter.

Medication supply specialist Catalent will provide vial filling and packaging services for the coronavirus vaccine candidate mRNA-1273 from drug maker Moderna, the companies said.

The agreement also involves Catalent, Somerset, NJ, providing additional staff at Catalent’s biological facilities in Bloomington, Indiana.

Employees will support the production of an initial dose of 100 million of the drug to supply the US market starting in the third quarter of this year.